CHRAC1 and pancreatic adenocarcinoma: Additionally, the CHRAC1 level was significantly associated with pathological stages of kidney renal clear cell carcinoma (KIRC), adrenocortical carcinoma (ACC) and PAAD patients (Fig. S2).